We read with attention the letter from Kelsey and Smet discussing the interpretation of our findings.
Kelsey et al1 questioned the validity of our findings regarding the high detection rate of methoxyacetic acid (MAA) we observed in our population despite the restriction in use of its precursors in Europe. First, human biomonitoring studies on glycol ether (GE) exposure in the non-occupational context are very few but other recent studies have also reported a high detection rate of MAA in the European general population in 2007–2009: MAA was detected in 99% and 100% of urine samples with a median concentration of 0.05 mg/L and 0.11 mg/L in a German2 and a French population,3 respectively. Second, regarding the sources of exposure to diethylene glycol monomethyl ether (DEGME) and triethylene glycol monomethyl ether (TEGME) as potential precursors of MAA detected in our study population, the period of recruitment (2002–2006) of the pregnant women...
https://ift.tt/2xadqB5
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου